| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |